Axel Dalhoff
Impact in
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 81
- Antibiotics Pharmacokinetics and Efficacy 80
-
- Antibiotic Resistance in Bacteria 25
- Co-authors
- Itamar Shalit (1 shared paper)Dagmar Kubitza (1 shared paper)Franz‐Josef Schmitz (1 shared paper)Sabine Schubert (11 shared papers)W. Weidner (2 shared papers)U. Ullmann (7 shared papers)Tom Bergan (1 shared paper)Heinz-Georg Wetzstein (1 shared paper)
- Journals
- Infection (25 papers)Antimicrobial Agents and Chemotherapy (15 papers)Chemotherapy (9 papers)Journal of Antimicrobial Chemotherapy (8 papers)European Journal of Clinical Microbiology & Infectious Diseases (8 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Axel Dalhoff
110 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 108
- Pharmacology 1.1k
- Molecular Medicine 366
- Applied Microbiology and Biotechnology 124
- Microbiology 116
- Infectious Diseases 325
Countries citing papers authored by Axel Dalhoff
This map shows the geographic impact of Axel Dalhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Dalhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Dalhoff more than expected).
Fields of papers citing papers by Axel Dalhoff
This network shows the impact of papers produced by Axel Dalhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Dalhoff. The network helps show where Axel Dalhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Axel Dalhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 268 | |
| 2 | 2003 | 264 | |
| 3 | 1999 | 177 | |
| 4 | 2005 | 160 | |
| 5 | 2003 | 118 | |
| 6 | 1988 | 104 | |
| 7 | 1997 | 86 | |
| 8 | 2004 | 66 | |
| 9 | 2002 | 63 | |
| 10 | 2009 | 63 | |
| 11 | 1994 | 59 | |
| 12 | 1999 | 54 | |
| 13 | 1998 | 53 | |
| 14 | 1997 | 52 | |
| 15 | 1999 | 51 | |
| 16 | 2010 | 51 | |
| 17 | 1985 | 49 | |
| 18 | 2005 | 49 | |
| 19 | 1986 | 48 | |
| 20 | 1988 | 48 |
About Axel Dalhoff
Axel Dalhoff is a scholar working on Pharmacology, Molecular Medicine, Infectious Diseases, Microbiology and Clinical Biochemistry, having authored 118 papers that have together received 3.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (80 papers), Antibiotic Resistance in Bacteria (25 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Urinary Tract Infections Management (7 papers), Bacterial biofilms and quorum sensing (7 papers), Bacterial Genetics and Biotechnology (7 papers), Antimicrobial agents and applications (6 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Pharmacology (1.1k citations), Molecular Medicine (366 citations), Applied Microbiology and Biotechnology (124 citations), Microbiology (116 citations) and Infectious Diseases (325 citations). Axel Dalhoff has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Itamar Shalit, Dagmar Kubitza, Franz‐Josef Schmitz, Sabine Schubert, W. Weidner, U. Ullmann, Tom Bergan, Heinz-Georg Wetzstein, Rolf W. Rohwedder and Marc Stadler. Their work appears in journals such as Infection, Antimicrobial Agents and Chemotherapy, Chemotherapy, Journal of Antimicrobial Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.